Navigation Links
GBC Seeks Nominations for Region's Third Annual Bioscience Awards
Date:1/14/2008

BALTIMORE, Jan. 14 /PRNewswire-USNewswire/ -- The Greater Baltimore Committee is seeking nominations for the Third Annual Greater Baltimore Region Bioscience Awards to be held on Tuesday, March 18, 2008. Those interested in nominating a company or individual for an award, visit http://www.gbc.org.

The four award categories are: Entrepreneurial, Best New Product or Progress, Leadership in Bioscience, and President's Award. Nominators will be asked to submit documentation and narratives that fulfill several criteria and then to add other supporting evidence as deemed suitable. Self-nominations are accepted and encouraged. Nominations will close on March 10, 2008.

"We want to make sure that the researcher with a marketable idea, the mid-sized medical device company and all in the region's bioscience industry know that we appreciate the contribution they are making to our economy," said Donald C. Fry, President and CEO of the Greater Baltimore Committee.

Judges for the awards are: Ravinder Dhallan, M.D./Ph.D., M.B.A., chairman and chief executive officer, Ravgen; Steve Dubin, chief executive officer, Martek Biosciences Corporation; Aaron H. Heifetz, Ph.D., vice president business development, Cognate BioServices, Inc.; James Hughes, vice president research and development, University of Maryland, Baltimore; Shira Kramer, Ph.D., president, Sterilex Corporation; and Mark E. Rapson, CPA, shareholder and leader, Health & Life Science Group, KAWG&F.

Program sponsor for the event is KAWG&F. Media sponsor is The Daily Record.

For more information, contact Lisbeth Pettengill at the Greater Baltimore Committee, 410-727-2820 or email to lisbethp@gbc.org.


'/>"/>
SOURCE Greater Baltimore Committee
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
2. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
3. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
4. Genoptix Reports Strong Financial Results For Third Quarter 2007
5. International Human Rights Day Recognized by Terasem Movement, Inc.s Third Annual Colloquium on the Law of Transbeman Persons
6. Reminder: Exelixis Announces December 5 Webcast of Its Third Annual R&D Day
7. Carrington Reports Third Quarter 2007 Results
8. Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results
9. China Kangtai Cactus Biotech, Inc. Reports Third Quarter 2007 Financial Results
10. China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results
11. Healthcare Technologies Reports 2007 Nine Months & Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... report analyzes the worldwide markets for Biostimulants in US$ by ... Extract Based, and Others. The report also analyzes the Global ... Crops, and Others. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... of World. Annual estimates and forecasts are provided for the ...
(Date:12/8/2016)... Dec. 8, 2016  Biotheranostics today announced that ... of the Breast Cancer Index (BCI) in identifying ... are most at-risk for disease recurrence and might ... from three studies advancing the understanding of the ... tumor biology and inform decisions related to patient ...
(Date:12/8/2016)... 2016 Oxford Gene ... seine Palette an anpassbaren SureSeq™ NGS-Panels mit dem ... das ein schnelles und kostengünstiges Studium der Varianten ... eine Erkennung von Einzel-Nukleotid-Variationen (Single Nucleotide Variation, SNV) ... kleinen Panel und ermöglicht eine individuelle Anpassung durch ...
(Date:12/8/2016)... Francisco, CA (PRWEB) , ... December 08, 2016 ... ... Oculus as finalists in the World Technology Awards. uBiome is one of just ... received across all categories. , In addition to uBiome, companies nominated as finalists ...
Breaking Biology Technology:
(Date:12/7/2016)... AVIV, Israel , December 7, 2016 ... with the expansion of its patent portfolio, which grew to over 40 ... , , ... by its recently filed patent entitled " System, Device, and ... covers technology that enables device makers to forego costly hardware components needed ...
(Date:12/6/2016)... Dec. 6, 2016 Valencell , the leading ... has seen a third consecutive year of triple digit ... in 2016 with a 360 percent increase in companies ... increase was driven by sales of its wrist and ... in its technology for hearables for fitness and healthcare ...
(Date:12/2/2016)... AUSTIN, Texas , Dec. 1, 2016 /PRNewswire/ ... provider, today announced BioLock , an electrocardiogram ... and health monitoring, a key IoT asset. The ... embedded into a vehicle,s steering wheel and mobile ... a simple touch. As vehicle technology ...
Breaking Biology News(10 mins):